Lataa...
Timing of multikinase inhibitor initiation in differentiated thyroid cancer
There are limited treatment options for patients with radioactive iodine refractory, progressive differentiated thyroid cancer. Although there is consensus that multikinase inhibitor therapy should be considered in patients with progressive disease with considerable tumor load or symptomatic disease...
Tallennettuna:
| Julkaisussa: | Endocr Relat Cancer |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Bioscientifica Ltd
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5446590/ https://ncbi.nlm.nih.gov/pubmed/28270435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0016 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|